Selective Biosensor Research Articles

The Study of Sensing Elements Parameters Optimization for Developed Biosensor of SARS-CoV-2 Detection

New advancements in developing sensitive and selective biosensors have demonstrated outstanding potential for Deoxyribonucleic Acid (DNA biosensors). The detection mode of DNA biosensors primary depends on a particular DNA hybridization that precisely occurs on the surface of the physical transducer that can only be detected using high-performance assays due to slight current changes. The analytical performance (sensitivity) of the DNA biosensor is conclusively rely on the confluence constructing of the sensing surface, which must be optimized. Thus, in this study, the sensing elements of the developed biosensors were optimized for detecting RNA of SARS-CoV-2. This optimization included concentration of nanomaterials (carbon quantum dots), probe density (concentration of DNA probe) and concentration of linker (APTES). It was observed that 0.15 % V/V of concentration CQD, 0.1μM of DNA probe and 36% V/V of APTES were the optimum parameters which provided their maximum response during electrical measurements and increased the sensitivity of the developed biosensor for SARS-CoV-2 detection.

Carbon Nanotubes and Their Composites for Flexible Electrochemical Biosensors

AbstractFlexible biosensors play a crucial role for healthcare management and disease diagnosis. Electrochemical biosensors have attracted significant attention for wearable sensing applications owing to their numerous advantages, including high sensitivity and selectivity, inherent miniaturization and rapid response times. Challenges lie in the development of highly conductive and flexible electrodes that can be integrated with biorecognition components to engineer selective biosensor interfaces. Carbon nanotubes (CNTs) hold significant promise as materials for wearable flexible sensor fabrication. This review highlights recent strategies for fabricating conductive and flexible electrodes, whether in the form of films or fibers, based on CNTs and their composites. Additionally, the review explores emerging biosensing applications, including flexible sensors for the direct electrochemical detection of biomarkers, sensors functionalized with enzymes, antibodies, or DNA, and sensors interfaced with cells to monitor transient biochemical signals.

Two-Dimensional TiS2 Nanosheet- and Conjugated Polymer Nanoparticle-Based Composites for Sensing Applications.

The assessment of phenolic compounds in food samples, environmental samples, and medical applications has gained importance recently. Here, we present research on novel conjugated polymer nanoparticles (P-PimBzBt NPs) and their composites with two-dimensional titanium disulfide nanosheets (2D-TiS2) for electrochemical tyrosinase (TYR)-based catechol detection. P-PimBzBt NPs are decorated with 2D-TiS2 to enhance the electrochemical performance for biosensing. In addition, the interaction of P-PimBzBt NPs with TiS2 was investigated at the molecular level by employing van der Waals (vdW) dispersion-corrected density functional theory (DFT) calculations and classical all-atom molecular dynamics simulations. According to the theoretical studies, the presence of the TiS2 layer increases the interfacial interaction with the conjugated polymer via electrostatic interactions. Using cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), field emission scanning electron microscopy (FE-SEM), and energy-dispersive X-ray spectroscopy (EDS) analyses, the production of SPE/TiS2@P-PimBzBt NPs/TYR nanobiosensors was examined. With a detection range of 3.0-27.5 μM, 0.33 μM LOD, and 3.89 μA/μM·cm2 sensitivity values, the sensing layer based on the TiS2@P-PimBzBt NP composites has a targeting ability toward catechol. Its selectivity was investigated using commonly used interfering ions and compounds such as citric acid, urea, glucose, uric acid, KCl, and NaCl. Application of nanobiosensors to actual samples (tap water and black tea) was carried out with high accuracy. The fabricated biosensing platform demonstrates that P-PimBzBt NPs with 2D-TiS2 nanomaterial functionalization are appropriate as electrode materials and could be used to create an inexpensive, fast-response, and highly selective electrochemical biosensor for the detection of catechol in actual samples.

A unique and convenient electrochemical biosensor for sodium based on a Na+-pumping rhodopsin

Sodium ion (Na+) detection plays a crucial role in various fields, including clinical diagnostics, environmental monitoring, and food quality control. However, existing techniques often lack sensitivity, selectivity, or practicality. This study presents a novel protein-based electrochemical biosensor for selective and quantitative Na+ detection, utilizing the microbial rhodopsin Nonlabens dokdonensis rhodopsin 2 (NdR2) reconstituted into liposome nanoparticles and immobilized on indium tin oxide (ITO) electrodes. Upon light illumination, the biosensor generates photocurrents proportional to the Na+ concentration in the sample. Extensive characterization unveiled the biosensor’s remarkable selectivity towards Na+ over other cationic species, including K+, Ca2+, Mg2+, and Cs+. Quantitative analysis revealed two linear response ranges: 2–50 mM and 50–200 mM, with a detection limit of 75 μM. The biosensor demonstrated exceptional thermal stability, withstanding 50 °C for 90 min with minimal signal deterioration. Long-term storage stability tests further highlighted its robustness, with consistent Na+ response for up to 17 days. Furthermore, the biosensor successfully detected Na+ in fetal bovine serum, although with a distinct photocurrent profile potentially influenced by interfering components. This pioneering work introduces a highly selective, sensitive, and stable protein-based biosensor for Na+ detection, offering promising implications for diverse applications in clinical diagnostics, environmental monitoring, and quality control, while paving the way for further advancements in biosensing technologies.

Selective and sensitive electroanalytical biosensor based on Poly([Cu(H2O)2P2]I2)/GCE for the determination of esomeprazole in pharmaceutical formulations and biological fluid samples

Selective and sensitive electroanalytical biosensor based on Poly([Cu(H2O)2P2]I2)/GCE for the determination of esomeprazole in pharmaceutical formulations and biological fluid samples

Enhanced performance of GO and RGO/Y2SiO5: Sm3+ nanocomposites for supercapacitors and biosensors

The increasing demand for high-performance materials in energy storage and biosensing applications highlights the need for ongoing research. Traditional materials often fail to meet the required standards for specific capacitance, energy density, and selectivity. Developing advanced nanocomposites, such as reduced graphene oxide (RGO) based Y2SiO5:Sm3+ (RYSOS), seeks to overcome these limitations, providing enhanced efficiency and stability. This study synthesized RYSOS nanocomposites for supercapacitor and biosensor applications, demonstrating superior performance over graphene oxide (GO) (GYSOS). RYSOS exhibited a higher specific capacitance of 474.81 Fg−1 compared to 396.68F−1 for GYSOS, and an energy density of 55.55 Wh/kg versus 32.89 Wh/kg. Additionally, RYSOS electrodes showed improved capacity retention at 87.83 % and coulombic efficiency at 91.54 % after 5000 cycles. In biosensing, RYSOS-modified carbon paste electrodes achieved excellent dopamine detection at pH 7.4, with a limit of detection (LOD) of 0.8579 µM and a limit of quantification (LOQ) of 2.859 µM. The developed electrode also demonstrated high selectivity for dopamine over uric acid and maintained 90 % stability over 10 cycles. These findings underscore the potential of RYSOS nanocomposites in enhancing the performance of advanced energy storage systems and biosensors, highlighting their effectiveness in specific capacitance, energy density, and selective biosensing capabilities.

Single molecule Lipid Biosensors Mitigate Inhibition of Endogenous Effector Proteins.

Genetically encoded lipid biosensors are essential cell biological tools. They are the only technique that provide real time, spatially resolved kinetic data for lipid dynamics in living cells. Despite clear strengths, these tools also carry significant drawbacks; most notably, lipid molecules bound to biosensors cannot engage with their effectors, causing inhibition. Here, we show that although PI 3-kinase (PI3K)-mediated activation of Akt is not significantly reduced in a cell population transfected with a PH-Akt1 PIP3/PI(3,4)P2 biosensor, single cells expressing the PH-Akt at visible levels (used for live-cell imaging) have no activated Akt at all. Tagging endogenous AKT1 with neonGreen at its genomic locus reveals its EGF-mediated translocation to the plasma membrane, accumulating at densities of ~0.3 molecules/μm2. Co-transfection with the PH-Akt biosensor or other PIP3 biosensors completely blocks this translocation, despite robust recruitment of the biosensors. A partial inhibition is even observed with PI(3,4)P2-selective biosensor. However, we found that expressing lipid biosensors at low levels, comparable with those of endogenous AKT, produced no such inhibition. Helpfully, these single-molecule biosensors revealed improved dynamic range and kinetic fidelity compared with over-expressed biosensor. This approach represents a less invasive way to probe spatiotemporal dynamics of the PI3K pathway in living cells.

A Plasmonic Nanoledge Array Sensor for Selective Detection of Cardiovascular Disease Biomarkers in Human Whole Blood.

Optical sensors face challenges when detecting ultralow amounts of analytes in whole blood, including signal quenching due to optical absorption and false positives due to nonspecific binding. This study introduces gold nanoscale array features termed nanoledges (NLs), which interact with incident white light to produce a transmitted surface plasmon resonance (tSPR) signal. This extraordinary optical transmission (EOT) spectrum occurs in the near-infrared (NIR) region, thereby minimizing signal quenching caused by visible-light absorption from blood proteins and pigments. To develop a sensitive, selective, and label-free optical biosensor for detecting various levels of cardiac troponin I (cTnI) in very small volumes of whole blood samples, DNA aptamers are tethered to the NL surface, specifically binding to the cTnI biomarker. This biological binding activity alters the refractive index at the NL surface, causing a peak shift in the EOT spectrum and enabling quantification of cTnI levels. The NL array chip demonstrated high sensitivity for cTnI detection in buffer, human serum (HS), and human whole blood (HB), with detection limits of 0.079, 0.084, and 0.097 ng/mL, respectively. Control measurements using blank target mediums and those containing up to 125 ng/mL of other proteins, such as myoglobin, creatine kinase, and heparin, showed minimal interference and high specificity. The NL plasmonic array's performance in biosensing underscores its promise for clinical analysis and its potential development as a point-of-care platform for early cardiovascular disease (CVD) diagnostics.

Surface-engineered vertically-aligned ZnO nanorod for sensitive non-enzymatic electrochemical monitoring of cholesterol

Developing highly sensitive and selective non-enzymatic electrochemical biosensors for disease biomarker detection has become challenging in healthcare applications. However, advances in material science are opening new avenues for creating more dependable biosensing technologies. In this context, the present work introduces a novel approach by engineering a hybrid structure of zinc oxide nanorod (ZnO NR) modified with iron oxide nanoparticle (Fe2O3 NP) on an FTO electrode. This Fe2O3 NP-ZnO NR hybrid material functions as a nanozyme, facilitating the catalysis of cholesterol and enabling the direct transfer of electrons to the fluorine-doped tin oxide (FTO) electrode, limiting the need for costly and traditional enzymes in the detection process. This innovative non-enzymatic cholesterol biosensor showcases remarkable sensitivity, registering at 642.8 μA/mMcm2 within a linear response range of up to 9.0 mM. It also exhibits a low detection limit (LOD) of ∼12.4 μM, ensuring its capability to detect minimal concentrations of cholesterol accurately. Moreover, the developed biosensor displays exceptional selectivity by effectively distinguishing cholesterol molecules from other interfering biological species, while exhibiting outstanding stability and reproducibility. Our findings indicate that the Fe2O3 NP-ZnO NR hybrid nanostructure on the FTO electrode holds promise for enhancing biosensor stability. Furthermore, the present device fabrication platform offers versatility, as it can be adapted with various enzymes or modified with different metal oxides, potentially broadening its applicability in a wide range of biomarkers detection.

A smart mask for exhaled breath condensate harvesting and analysis.

Recent respiratory outbreaks have garnered substantial attention, yet most respiratory monitoring remains confined to physical signals. Exhaled breath condensate (EBC) harbors rich molecular information that could unveil diverse insights into an individual's health. Unfortunately, challenges related to sample collection and the lack of on-site analytical tools impede the widespread adoption of EBC analysis. Here, we introduce EBCare, a mask-based device for real-time in situ monitoring of EBC biomarkers. Using a tandem cooling strategy, automated microfluidics, highly selective electrochemical biosensors, and a wireless reading circuit, EBCare enables continuous multimodal monitoring of EBC analytes across real-life indoor and outdoor activities. We validated EBCare's usability in assessing metabolic conditions and respiratory airway inflammation in healthy participants, patients with chronic obstructive pulmonary disease or asthma, and patients after COVID-19 infection.

Bioinspired synergy strategy based on the integration of nanozyme into a molecularly imprinted polymer for improved enzyme catalytic mimicry and selective biosensing

Nanozymes offer many advantages such as good stability and high catalytic activity, but their selectivity is lower than that of enzymes. This is because most of enzymes have a protein component (apoenzyme) for substrate affinity to enhance selectivity and a non-protein element (coenzyme) for catalytic activity to improve sensitivity. The synergy between molecularly imprinted polymers (MIPs) and nanozymes can mimic natural enzymes, with MIP acting as the apoenzyme and nanozyme as the coenzyme. Despite researchers' attempts to associate MIPs with nanozymes, the full potential of this combination remains not well explored. This study addresses this gap by integrating Fe3O4-Lys-Cu nanozymes with peroxidase-like catalytic activities within appropriate MIPs for L-DOPA and dopamine. The catalytic performance of the nanozyme was improved by the presence of Cu in Fe3O4-Lys-Cu and further enhanced by MIP. Indeed, the exploration of the pre-concentration property of MIP has increased twenty-fold the catalytic activity of the nanozyme. Moreover, this synergistic combination facilitated the template removal process during MIP production by reducing the extraction time from several hours to just 1 min thanks to the addition of co-substrates which trigger the reaction with nanozyme and release the template. Overall, the synergistic combination of MIPs and nanozymes offers a promising avenue for the design of artificial enzymes.

Nuclear Chloride Ion-Selective Fluorescent Probe and Its Biological Applications.

Owing to the biological significance of Cl- in cells, several chemical fluorescent probes and biosensors have been constructed to monitor this anion in the cytosol and subcellular organelles. However, a fluorescent probe for the selective detection of nuclear Cl- has not been described thus far. In the current study, we developed the first nuclear Cl--selective biosensor, Cl-YFP-NLS, whose fluorescence was effectively quenched by this anion, and demonstrated that it is an efficient and powerful tool for determining the levels of nuclear Cl-. The results of cell studies using Cl-YFP-NLS as the probe suggested that the level of Cl- in the nucleus is lower than that in the cytosol. In addition, Cl-YFP-NLS along with lysosomal (Lyso-MQAE) and mitochondrial Cl--selective fluorescent probes (Mito-MQAE) were utilized to determine the effects of various substances on the levels of Cl- in subcellular organelles. The results showed that lysosomotropic agents decrease the lysosomal Cl- concentration and increase the levels of mitochondrial and nuclear Cl-. Also, observations suggested that substances capable of inducing mitochondrial outer membrane permeabilization without inducing lysosomal membrane permeabilization increase mitochondrial and nuclear Cl- concentrations but they do not affect the level of lysosomal Cl-. Moreover, a substance directly disrupting nuclear pore complexes increased the level of nuclear Cl- and did not change the levels of lysosomal and mitochondrial Cl-. Finally, nucleus-affecting substances that cause deoxyribonucleic acid damage and activate p53 and Bax increased the levels of mitochondrial and nuclear Cl- without influencing the level of lysosomal Cl-.

Fabrication of a highly sensitive conductive copolymer layer modified immunosensing tool for cytokeratin-19 fragment detection

Design of a new and highly selective impedimetric biosensor based on the immobilization of a fragment of cytokeratin subunit 19 (CYFRA 21-1)-specific antibodies onto a conductive copolymer layer (poly(epoxy-substituted thiophene)-co-poly(3,4-ethylenedioxythiophene), CCL)-coated indium tin oxide (ITO) for the determination of CYFRA 21-1 in serum samples was reported. CCL was applied as a working electrode-modifying reagent to prepare the surface of the working ITO electrode, and CYFRA 21-1-specific antibodies bound to epoxy ends present in the copolymer layer matrix. The impedimetric response of the immunosensor to CYFRA 21-1 was recorded, and the signaling mechanism of the suggested immunosensor was based on an increase in the charge transfer resistance in the presence of target CYFRA 21-1. The developed biosensor exhibited excellent selectivity for CYFRA 21-1, and it could detect CYFRA 21-1 in a linear dynamic range from 0.0125 to 35 pg/mL with a limit of quantification (LOQ) of 12.25 fg/mL. The designed biosensor showed good storage stability, high sensitivity, suitable repeatability and reproducibility, and acceptable long-term stability. The clinical analysis of the manufactured immunosensor was explored for the analysis of serum samples, and high recoveries and good relative standard deviations (RSDs) were obtained in the range of 97.01 and 103.17 %, respectively. This copolymer-based biosensor could be a feasible tool for clinical diagnosis in complex serum samples.

Enhance electrochemical sensing of ascorbic acid and dopamine using V-CuO/GO nanocomposite

The electrochemical detection of Ascorbic acid and dopamine is crucial due to their vital roles in biological processes. Both biomolecules coexist in the human body and have the same oxidation potential, leading to electrode fouling and overlapping of oxidation potential. Accurate detection enables monitoring their levels in biological samples, aiding in disease diagnosis and treatment. This study presents the fast and green synthesis of a highly sensitive and selective electrochemical biosensor for the simultaneous detection of dopamine and ascorbic acid. The change in spherical cluster morphology into nanorods enhances the electrode's electroactive surface area, enhancing sensor sensitivity and selectivity. Electrochemical characterization techniques, including cyclic voltammetry and electrochemical impedance spectroscopy, demonstrated excellent electron transportation and low charge transfer resistance. The sensor exhibited simultaneous detection with a low limit of detection of 8 µM for dopamine and 6.9 µM for ascorbic acid, with a wide linear working range. Additionally, the sensor showed excellent selectivity and repeatability with a vast potential gap at simultaneous detection, making it suitable for clinical and food industry applications.

Electrochemical aptasensor based on RGO/PPy/Au*NPs for diagnostic biosensing of SARS-CoV-2 in clinical samples: Experimental and molecular dynamics simulations approaches

A highly sensitive and selective E-DNA biosensor was fabricated on a gold substrate using a reduced graphene oxide/polypyrrole/gold nanoparticle/oligonucleotide (RGO/PPy/Au*NPs/Apt) nanocomposite electrode to detect the nucleocapsid protein of SARS-CoV-2 in the patient blood plasma. The modified electrode was characterized by physicochemical techniques such as Fourier transform-infra red (FT-IR), Raman spectroscopy, X-ray diffraction (XRD), energy-dispersive X-ray (EDX) spectroscopy, X-ray photoelectron spectroscopy (XPS) analyses, Brunauer-Emmett-Teller (BET), and Barrett-Joyner-Halenda (BJH) analyses. Moreover, electrochemical analyses were employed to study the electrochemical performance of the electrodes including cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), and square wave voltammetry (SWV). Computational investigations of N protein bindings such as hydrogen bonding, Van der Waals binding, and Gibbs binding energies of the N-protein, and aptamer were studied by Molecular Dynamics Simulations (MDS). The unique synergistic effect of RGO, PPy, and the well-known effect of Au nanoparticles makes the DNA probe immobilized on the gold electrode surface. After optimizing the systems, the E-DNA biosensor exhibited a fast SWV response, higher sensitivity (33.77 μA.nM−1.cm−2) and selectivity, high efficiency, good storage stability, and acceptable repeatability for monitoring DNA. The results of real samples based on SWV indicated the correct functioning of the aptasensor in the presence of the SARS-CoV-2 virus. The limit of detection was 3.16×10−17 M and the limit of quantitation was 1.42×10−16 M. The MDS results indicated the stable dynamic folding of the aptamer for beneficial binding. The results indicated that the RGO/PPy/Au*NPs/Apt biosensor is promising for detecting of SARS-CoV-2 virus.

Thermo-Switchable Enzyme@Metal-Organic Framework for Selective Biocatalysis and Biosensing.

The stimulus-responsive regulation of enzyme catalytic activity and selectivity provides a new opportunity to extend the functionality and efficiency of immobilized enzymes. This work aims to design and synthesize a thermo-switchable enzyme@MOF for size-selective biocatalysis and biosensing through the immobilization of Candida rugosa lipase (CRL) within ZIF-8 functionalized with thermally responsive polymer, poly(N-isopropylacrylamide) (PNIPAM) (CRL@ZIF-8-PNIPAM). Unlike free CRL, which does not demonstrate substrate selectivity, we can reversibly tune the pore size of the ZIF-8-PNIPAM nanostructures (open pores or blocked pores) through temperature stimulus and subsequently modulate the substrate selectivity of CRL@ZIF-8-PNIPAM. CRL@ZIF-8-PNIPAM had the highest hydrolytic activity for small molecules (12 mM p-nitrophenol/mg protein/min, 4-nitrophenyl butyrate (p-NP Be)) and the lowest hydrolytic activity for large molecules (0.16 mM p-nitrophenol/mg protein/min, 4-nitrophenyl palmitate (p-NP P)). In addition, CRL@ZIF-8-PNIPAM demonstrated thermo-switchable behavior for large molecules (p-NP P). The p-NP P hydrolytic activity of CRL@ZIF-8-PNIPAM was significantly lower at 40 °C (blocked pores) than at 27 °C (open pores). However, the transition of blocked pores and open pores is a gradual process that resulted in a delay in the "thermo-switchable" catalytic behavior of CRL@ZIF-8-PNIPAM during thermal cycling. CRL@ZIF-8-PNIPAM was also successfully used for the fabrication of electrochemical biosensors for the selective biosensing of pesticides with different molecular sizes.

Hollow Carbon Nanorods Modified Screen Printed Electrodes for Sensitive Lactate Biosensing

AbstractThis novel work details the development and comprehensive characterization of a highly sensitive and selective lactate biosensor system, leveraging the modification of screen‐printed electrodes (SPEs) with hollow carbon nanorods (HCNs). The HCN synthesis involved a multi‐step procedure utilizing iron (III) oxyhydroxide (β‐FeOOH) nanorods as sacrificial templates. Extensive characterization through field emission scanning electron microscopy (FE‐SEM) and X‐ray diffraction (XRD) substantiated the successful fabrication of HCNs replete with substantial cavities. To assess the efficacy of surface modification, HCNs were applied to SPEs using drop casting and electrodeposition methods, enabling a comparative analysis of these techniques in the context of biosensor systems. Lactate detection was accomplished effectively, revealing a linear range of 1 μM to 300 μM for drop casting and 10 μM to 300 μM for electrodeposition, with corresponding limit of detection (LOD) values of 0.55 μM and 2.8 μM. The biosensor system exhibited exceptional stability, repeatability, and selectivity. Furthermore, real sample analyses employing spiked serum samples demonstrated remarkable accuracy, achieving recoveries of up to 109 % for drop casting and 111 % for electrodeposition methods. In summary, the presented HCN‐modified SPEs offer a highly sensitive, selective, and stable platform for lactate detection, showcasing their significant potential across a spectrum of applications, including clinical diagnostics and bioprocess monitoring.

Harnessing the Synergy of ZIF‐67 Derived Nanohybrid‐Based Immunosensing for sensitive Detection of Helicobacter pylori

AbstractDetection of Helicobacter pylori (H. pylori) infection, a significant risk factor for chronic gastritis, peptic ulcers, and gastric adenocarcinoma, poses a formidable challenge due to the lack of sensitive and selective sensing platforms. Herein, we report the synthesis of a zeolitic imidazolate framework‐67 (ZIF‐67) derived Co/Co3O4/C (CoNH) porous nanostructure, optimized for the electrochemical immunosensing of H. pylori‐specific antigen VacA. By calcining ZIF‐67 at elevated temperatures, we obtained CoNH with enhanced electroactivity and conductivity, crucial for signal enhancement. The synthesized CoNH was thoroughly characterized using SEM, TEM, XPS, Raman, and FT‐IR techniques. Further signal amplification was achieved by introducing gold nanoparticles (AuNPs) onto CoNH‐modified screen‐printed carbon electrodes. Systematic investigation at each modification stage led to an optimized immunosensing platform with high sensitivity and selectivity for VacA detection. The developed immunosensor demonstrated the capability to detect low concentrations of VacA (0.1 ng/ml) within a wide linear range (0.1–50 ng/ml) with long‐term stability. This highly sensitive and selective biosensor holds promise for early‐stage diagnosis of H. pylori infection and gastric cancer.

Designing Nanocomposite-Based Electrochemical Biosensors for Diabetes Mellitus Detection: A Review.

This review will unveil the development of a new generation of electrochemical sensors utilizing a transition-metal-oxide-based nanocomposite with varying morphology. There has been considerable discussion on the role of transition metal oxide-based nanocomposite, including iron, nickel, copper, cobalt, zinc, platinum, manganese, conducting polymers, and their composites, in electrochemical and biosensing applications. Utilizing these materials to detect glucose and hydrogen peroxide selectively and sensitively with the correct chemical functionalization is possible. These transition metals and their oxide nanoparticles offer a potential method for electrode modification in sensors. Nanotechnology has made it feasible to develop nanostructured materials for glucose and H2O2 biosensor applications. Highly sensitive and selective biosensors with a low detection limit can detect biomolecules at nanomolar to picomolar (10-9 to 10-12 molar) concentrations to assess physiological and metabolic parameters. By mixing carbon-based materials (graphene oxide) with inorganic nanoparticles, nanocomposite biosensor devices with increased sensitivity can be made using semiconducting nanoparticles, quantum dots, organic polymers, and biomolecules.

Image Sensing of Gaseous Acetone Using Secondary Alcohol Dehydrogenase-Immobilized Mesh for Exhaled Air.

Human-borne acetone is a potent marker of lipid metabolism. Here, an enzyme immobilization method for secondary alcohol dehydrogenase (S-ADH), which is suitable for highly sensitive and selective biosensing of acetone, was developed, and then its applicability was demonstrated for spatiotemporal imaging of concentration distribution. After various investigations, S-ADH-immobilized meshes could be prepared with less than 5% variation by cross-linking S-ADH with glutaraldehyde on a cotton mesh at 40 °C for 15 min. Furthermore, high activity was obtained by adjusting the concentration of the coenzyme nicotinamide adenine dinucleotide (NADH) solution added to the S-ADH-immobilized mesh to 500 μM and the solvent to a potassium phosphate buffer solution at pH 6.5. The gas imaging system using the S-ADH-immobilized mesh was able to image the decrease in NADH fluorescence (ex 340 nm, fl 490 nm) caused by the catalytic reaction of S-ADH and the acetone distribution in the concentration range of 0.1-10 ppm-v, including the breath concentration of healthy people at rest. The exhaled breath of two healthy subjects at 6 h of fasting was quantified as 377 and 673 ppb-v, which were consistent with the values quantified by gas chromatography-mass spectrometry.